Hospitals persistently use outdated next-of-kin records, contact unauthorized family for non-emergencies, and disclose PHI despite patient do-not-release instructions, with poor access to logs or accountability.
Hospitals retain and use outdated next-of-kin or emergency contact information despite patients explicitly listing individuals to exclude and providing updated contacts.
Michigan. Hospital listed my estranged father as next of kin and gave him information after I told them not to
Michigan. Hospital listed my estranged father as next of kin and gave him information after I told them not to
There is no private cause of action under HIPAA.
commentThere is no private cause of action under HIPAA. This means you cannot sue for a HIPAA violation under HIPAA. But you can start the complaint process: https://www.hhs.gov/hipaa/filing-a-complaint/index.html. You do not need an attorney and there won’t be any payout, let alone a “giant payout”. You are probably not entitled to the name of the specific staff members who accessed your records but you can request an audit. Direct this request to the hospital’s privacy team (or similar title - may be under “compliance”). I suggest you send these requests via email and via certified mail. Now is a good time to review your contacts for all medical providers. You don’t need to disclose the reasons why someone is not listed as a contact (or why someone is specifically listed as a “do not contact”).
Why are they calling next of kin anyway when you already gave them a current contact?
commentWhy are they calling next of kin anyway when you already gave them a current contact? Unless something went horribly wrong, there was no reason for them to be reaching out to anyone in the first place!
Adults who have updated emergency contacts and explicitly listed family to exclude after life changes or estrangement, but face repeated hospital violations.
Multiple repeated complaints about outdated contacts used post-update and unauthorized non-emergency calls across patients.
Patient-first enforcement layer focused on contact directives rather than full records or general HIPAA portals; provides actionable proof and escalation vs passive storage.
A patient app to create, legally format, and digitally deliver enforceable Medical Contact Directives to hospitals, with automated tracking, breach reporting, and escalation templates.
Patients already invest repeated time updating forms and filing complaints; quotes show deep frustration and desire for accountability where HIPAA offers no private lawsuit. $9/mo is low compared to emotional/financial cost of unauthorized disclosures.
“Lock your medical contacts and get proof hospitals honor it.”
A patient app to create, legally format, and digitally deliver enforceable Medical Contact Directives to hospitals, with automated tracking, breach reporting, and escalation templates.
Target patient forums (Reddit r/estranged, r/HIPAA, surgery recovery groups) and partnerships with patient advocacy organizations.
Hospitals may ignore or slow-walk patient-submitted digital forms, limiting perceived value.
No private HIPAA right of action means tool provides documentation but not guaranteed remedies.
Patients struggle to find the right compliance email/address for each facility.
Patients may treat this as one-time setup rather than recurring need.
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoThis idea scores in the upper-middle range of opportunities surfaced by MonetScope, with a validation sub-score of 8/10 against 4 independently sourced evidence signals. A "promising" rating usually indicates a real pain has been detected and discussed in the open, but the pipeline did not find enough signal to flag it as urgent or high-frequency. These opportunities can still produce excellent businesses — they often correspond to "boring" problems that established players have ignored — but the founder should expect a longer customer-development cycle to confirm willingness to pay.
It sits at the intersection of "automation", "compliance", "healthcare", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.
